These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 33283341)
21. Synthesis and evaluation of new dinitrobenzamide mustards in human prostate cancer. Basiri A; Zhang W; Garrison J Bioorg Med Chem Lett; 2021 Jan; 31():127697. PubMed ID: 33220402 [TBL] [Abstract][Full Text] [Related]
22. Synthesis and antitumor activity of novel nitrogen mustard-linked chalcones. Fang X; Yang B; Cheng Z; Yang M; Su N; Zhou L; Zhou J Arch Pharm (Weinheim); 2013 Apr; 346(4):292-9. PubMed ID: 23519571 [TBL] [Abstract][Full Text] [Related]
23. [Synthesis of a potential metabolite of the carcinostatic bendamustin (Cytostasen)]. Werner W; Letsch G; Ihn W; Sohr R; Preiss R Pharmazie; 1991 Feb; 46(2):113-4. PubMed ID: 1852759 [TBL] [Abstract][Full Text] [Related]
24. Benzoyl and cinnamoyl nitrogen mustard derivatives of benzoheterocyclic analogues of the tallimustine: synthesis and antitumour activity. Baraldi PG; Romagnoli R; Giovanna Pavani M; del Carmen Nunez M; Bingham JP; Hartley JA Bioorg Med Chem; 2002 May; 10(5):1611-8. PubMed ID: 11886822 [TBL] [Abstract][Full Text] [Related]
25. Therapeutic journery of nitrogen mustard as alkylating anticancer agents: Historic to future perspectives. Singh RK; Kumar S; Prasad DN; Bhardwaj TR Eur J Med Chem; 2018 May; 151():401-433. PubMed ID: 29649739 [TBL] [Abstract][Full Text] [Related]
26. Cross-linking of the DNA repair protein Omicron6-alkylguanine DNA alkyltransferase to DNA in the presence of antitumor nitrogen mustards. Loeber R; Michaelson E; Fang Q; Campbell C; Pegg AE; Tretyakova N Chem Res Toxicol; 2008 Apr; 21(4):787-95. PubMed ID: 18324787 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents. Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783 [TBL] [Abstract][Full Text] [Related]
28. Potent antitumor N-mustard derivatives of 9-anilinoacridine, synthesis and antitumor evaluation. Bacherikov VA; Chou TC; Dong HJ; Chen CH; Lin YW; Tsai TJ; Su TL Bioorg Med Chem Lett; 2004 Sep; 14(18):4719-22. PubMed ID: 15324894 [TBL] [Abstract][Full Text] [Related]
29. Potential anticancer agents. XX. 2. Quantitative structure--activity relationships (QSAR) in aromatic nitrogen mustards area. Niculescu-Duvăz I; Stihi G; Crăescu T; Simon Z Neoplasma; 1980; 27(3):271-8. PubMed ID: 7453847 [TBL] [Abstract][Full Text] [Related]
30. Structure-activity relationship of a series of nitrogen mustard- and pyrrole-containing minor groove-binding agents related to distamycin. Wyatt MD; Garbiras BJ; Haskell MK; Lee M; Souhami RL; Hartley JA Anticancer Drug Des; 1994 Dec; 9(6):511-25. PubMed ID: 7880376 [TBL] [Abstract][Full Text] [Related]
31. Bendamustine hydrochloride activity against doxorubicin-resistant human breast carcinoma cell lines. Strumberg D; Harstrick A; Doll K; Hoffmann B; Seeber S Anticancer Drugs; 1996 Jun; 7(4):415-21. PubMed ID: 8826610 [TBL] [Abstract][Full Text] [Related]
32. Structure-activity relationship of a series of C-terminus modified aminoalkyl, diaminoalkyl- and anilino-containing analogues of the benzoic acid mustard distamycin derivative tallimustine: synthesis, DNA binding and cytotoxicity studies. Brooks N; Hartley JA; Simpson JE; Wright SR; Woo S; Centioni S; Fontaine MD; McIntyre TE; Lee M Bioorg Med Chem; 1997 Aug; 5(8):1497-507. PubMed ID: 9313856 [TBL] [Abstract][Full Text] [Related]
33. [Synthesis and antitumor activity of benzoic nitrogen mustard derivatives]. Luo W; Zhao YM; Wang YX; Xie SQ; Zhao J; Wang CJ Yao Xue Xue Bao; 2007 Dec; 42(12):1327-9. PubMed ID: 18338650 [TBL] [Abstract][Full Text] [Related]
34. The cytotoxicity, DNA crosslinking ability and DNA sequence selectivity of the aniline mustards melphalan, chlorambucil and 4-[bis(2-chloroethyl)amino] benzoic acid. Sunters A; Springer CJ; Bagshawe KD; Souhami RL; Hartley JA Biochem Pharmacol; 1992 Jul; 44(1):59-64. PubMed ID: 1632839 [TBL] [Abstract][Full Text] [Related]
35. Novel enmein-type diterpenoid hybrids coupled with nitrogen mustards: Synthesis of promising candidates for anticancer therapeutics. Gao X; Li J; Wang M; Xu S; Liu W; Zang L; Li Z; Hua H; Xu J; Li D Eur J Med Chem; 2018 Feb; 146():588-598. PubMed ID: 29407983 [TBL] [Abstract][Full Text] [Related]
36. Optimization of the N-lost drugs melphalan and bendamustine: synthesis and cytotoxicity of a new set of dendrimer-drug conjugates as tumor therapeutic agents. Scutaru AM; Wenzel M; Scheffler H; Wolber G; Gust R Bioconjug Chem; 2010 Oct; 21(10):1728-43. PubMed ID: 20849062 [TBL] [Abstract][Full Text] [Related]
37. Synthesis and preliminary cytotoxicity of nitrogen mustard derivatives of distamycin A. Wang Y; Wright SC; Larrick JW Bioorg Med Chem Lett; 2003 Feb; 13(3):459-61. PubMed ID: 12565950 [TBL] [Abstract][Full Text] [Related]
38. Hypoxia-selective antitumor agents. 12. Nitrobenzyl quaternary salts as bioreductive prodrugs of the alkylating agent mechlorethamine. Tercel M; Wilson WR; Anderson RF; Denny WA J Med Chem; 1996 Mar; 39(5):1084-94. PubMed ID: 8676343 [TBL] [Abstract][Full Text] [Related]
39. Nitrogen Mustards as Alkylating Agents: A Review on Chemistry, Mechanism of Action and Current USFDA Status of Drugs. More GS; Thomas AB; Chitlange SS; Nanda RK; Gajbhiye RL Anticancer Agents Med Chem; 2019; 19(9):1080-1102. PubMed ID: 30834842 [TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and biological evaluation of novel α-hederagenin derivatives with anticancer activity. Liu XX; Yang YT; Wang X; Wang KY; Liu JQ; Lei L; Luo XM; Zhai R; Fu FH; Wang HB; Bi Y Eur J Med Chem; 2017 Dec; 141():427-439. PubMed ID: 29040953 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]